Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies.

52W Range

91stpctl

Volume

0.71×avg

Market Cap

758.36MUSD

P/E Ratio

-15.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Immix Biopharma, Inc.

IMMXNASDAQ Capital Market·USD·Closed

Immix Biopharma, Inc.

IMMXNASDAQ·USD·Closed

$13.94

−2.59%

$13.94

−$0.37 (2.59%)

52W Range

91stpctl

Volume

0.71×avg

Mkt Cap

758.36MUSD

P/E

-15.8TTM

Div Yield

–ann

IMMX: Immix Biopharma, Inc. Stock Analysis | finqOS